DEXCOM INC (DC4.DE) Fundamental Analysis & Valuation

FRA:DC4 • US2521311074

Current stock price

54 EUR
-0.2 (-0.37%)
Last:

This DC4.DE fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

8

1. DC4.DE Profitability Analysis

1.1 Basic Checks

  • DC4 had positive earnings in the past year.
  • DC4 had a positive operating cash flow in the past year.
  • Each year in the past 5 years DC4 has been profitable.
  • In the past 5 years DC4 always reported a positive cash flow from operatings.
DC4.DE Yearly Net Income VS EBIT VS OCF VS FCFDC4.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 500M 1B

1.2 Ratios

  • DC4 has a Return On Assets of 13.19%. This is amongst the best in the industry. DC4 outperforms 93.44% of its industry peers.
  • Looking at the Return On Equity, with a value of 30.46%, DC4 belongs to the top of the industry, outperforming 96.72% of the companies in the same industry.
  • DC4 has a Return On Invested Capital of 18.92%. This is amongst the best in the industry. DC4 outperforms 96.72% of its industry peers.
  • Measured over the past 3 years, the Average Return On Invested Capital for DC4 is above the industry average of 10.31%.
  • The last Return On Invested Capital (18.92%) for DC4 is above the 3 year average (14.59%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 13.19%
ROE 30.46%
ROIC 18.92%
ROA(3y)10.24%
ROA(5y)8.29%
ROE(3y)28.01%
ROE(5y)22.13%
ROIC(3y)14.59%
ROIC(5y)11.66%
DC4.DE Yearly ROA, ROE, ROICDC4.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10 -10 20 -20 30

1.3 Margins

  • DC4 has a better Profit Margin (17.94%) than 93.44% of its industry peers.
  • In the last couple of years the Profit Margin of DC4 has declined.
  • The Operating Margin of DC4 (21.55%) is better than 83.61% of its industry peers.
  • DC4's Operating Margin has improved in the last couple of years.
  • DC4's Gross Margin of 62.09% is fine compared to the rest of the industry. DC4 outperforms 62.30% of its industry peers.
  • DC4's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 21.55%
PM (TTM) 17.94%
GM 62.09%
OM growth 3Y15.68%
OM growth 5Y5.09%
PM growth 3Y15.23%
PM growth 5Y-8.86%
GM growth 3Y-1.61%
GM growth 5Y-1.72%
DC4.DE Yearly Profit, Operating, Gross MarginsDC4.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 40 60

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

7

2. DC4.DE Health Analysis

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so DC4 is creating value.
  • DC4 has less shares outstanding than it did 1 year ago.
  • Compared to 5 years ago, DC4 has about the same amount of shares outstanding.
  • The debt/assets ratio for DC4 has been reduced compared to a year ago.
DC4.DE Yearly Shares OutstandingDC4.DE Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M
DC4.DE Yearly Total Debt VS Total AssetsDC4.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B

2.2 Solvency

  • DC4 has an Altman-Z score of 6.21. This indicates that DC4 is financially healthy and has little risk of bankruptcy at the moment.
  • Looking at the Altman-Z score, with a value of 6.21, DC4 belongs to the top of the industry, outperforming 88.52% of the companies in the same industry.
  • DC4 has a debt to FCF ratio of 1.20. This is a very positive value and a sign of high solvency as it would only need 1.20 years to pay back of all of its debts.
  • DC4's Debt to FCF ratio of 1.20 is amongst the best of the industry. DC4 outperforms 83.61% of its industry peers.
  • A Debt/Equity ratio of 0.47 indicates that DC4 is not too dependend on debt financing.
  • With a Debt to Equity ratio value of 0.47, DC4 perfoms like the industry average, outperforming 45.90% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.47
Debt/FCF 1.2
Altman-Z 6.21
ROIC/WACC2.3
WACC8.24%
DC4.DE Yearly LT Debt VS Equity VS FCFDC4.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B 2.5B

2.3 Liquidity

  • DC4 has a Current Ratio of 1.88. This is a normal value and indicates that DC4 is financially healthy and should not expect problems in meeting its short term obligations.
  • DC4 has a Current ratio (1.88) which is in line with its industry peers.
  • A Quick Ratio of 1.59 indicates that DC4 should not have too much problems paying its short term obligations.
  • The Quick ratio of DC4 (1.59) is better than 68.85% of its industry peers.
Industry RankSector Rank
Current Ratio 1.88
Quick Ratio 1.59
DC4.DE Yearly Current Assets VS Current LiabilitesDC4.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B 4B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

7

3. DC4.DE Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an nice 12.73% over the past year.
  • DC4 shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 19.29% yearly.
  • The Revenue has grown by 15.60% in the past year. This is quite good.
  • DC4 shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 19.33% yearly.
EPS 1Y (TTM)12.73%
EPS 3Y28.82%
EPS 5Y19.29%
EPS Q2Q%0%
Revenue 1Y (TTM)15.6%
Revenue growth 3Y17.01%
Revenue growth 5Y19.33%
Sales Q2Q%13.12%

3.2 Future

  • Based on estimates for the next years, DC4 will show a very strong growth in Earnings Per Share. The EPS will grow by 21.71% on average per year.
  • DC4 is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 11.94% yearly.
EPS Next Y36.73%
EPS Next 2Y27.84%
EPS Next 3Y25.1%
EPS Next 5Y21.71%
Revenue Next Year12.62%
Revenue Next 2Y12.47%
Revenue Next 3Y12.38%
Revenue Next 5Y11.94%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
  • The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
DC4.DE Yearly Revenue VS EstimatesDC4.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 2B 4B 6B 8B 10B
DC4.DE Yearly EPS VS EstimatesDC4.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 1 2 3 4

More info and screens

Find the best growth stocksShow best growing peers

4

4. DC4.DE Valuation Analysis

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 33.96 indicates a quite expensive valuation of DC4.
  • The rest of the industry has a similar Price/Earnings ratio as DC4.
  • The average S&P500 Price/Earnings ratio is at 27.42. DC4 is valued slightly more expensive when compared to this.
  • DC4 is valuated rather expensively with a Price/Forward Earnings ratio of 24.83.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of DC4 is on the same level as its industry peers.
  • When comparing the Price/Forward Earnings ratio of DC4 to the average of the S&P500 Index (22.24), we can say DC4 is valued inline with the index average.
Industry RankSector Rank
PE 33.96
Fwd PE 24.83
DC4.DE Price Earnings VS Forward Price EarningsDC4.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • DC4's Enterprise Value to EBITDA is on the same level as the industry average.
  • Compared to the rest of the industry, the Price/Free Cash Flow ratio of DC4 indicates a somewhat cheap valuation: DC4 is cheaper than 65.57% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 22.56
EV/EBITDA 17.92
DC4.DE Per share dataDC4.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8 10

4.3 Compensation for Growth

  • The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • The excellent profitability rating of DC4 may justify a higher PE ratio.
  • A more expensive valuation may be justified as DC4's earnings are expected to grow with 25.09% in the coming years.
PEG (NY)0.92
PEG (5Y)1.76
EPS Next 2Y27.84%
EPS Next 3Y25.1%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. DC4.DE Dividend Analysis

5.1 Amount

  • No dividends for DC4!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

DC4.DE Fundamentals: All Metrics, Ratios and Statistics

DEXCOM INC

FRA:DC4 (4/23/2026, 7:00:00 PM)

54

-0.2 (-0.37%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)02-12
Earnings (Next)04-30
Inst Owners101.29%
Inst Owner ChangeN/A
Ins Owners0.25%
Ins Owner ChangeN/A
Market Cap20.78B
Revenue(TTM)4.66B
Net Income(TTM)836.30M
Analysts84.86
Price Target76.2 (41.11%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-13.4%
Min EPS beat(2)-32.12%
Max EPS beat(2)5.32%
EPS beat(4)2
Avg EPS beat(4)-6.03%
Min EPS beat(4)-32.12%
Max EPS beat(4)6.77%
EPS beat(8)5
Avg EPS beat(8)-1.11%
EPS beat(12)9
Avg EPS beat(12)9.15%
EPS beat(16)11
Avg EPS beat(16)5.86%
Revenue beat(2)1
Avg Revenue beat(2)-0.14%
Min Revenue beat(2)-0.9%
Max Revenue beat(2)0.61%
Revenue beat(4)2
Avg Revenue beat(4)0.1%
Min Revenue beat(4)-0.9%
Max Revenue beat(4)0.88%
Revenue beat(8)2
Avg Revenue beat(8)-1.02%
Revenue beat(12)5
Avg Revenue beat(12)-0.35%
Revenue beat(16)6
Avg Revenue beat(16)-0.53%
PT rev (1m)0.25%
PT rev (3m)9.38%
EPS NQ rev (1m)0.17%
EPS NQ rev (3m)-0.35%
EPS NY rev (1m)0.03%
EPS NY rev (3m)0.86%
Revenue NQ rev (1m)-0.08%
Revenue NQ rev (3m)-0.58%
Revenue NY rev (1m)-0.02%
Revenue NY rev (3m)-0.04%
Valuation
Industry RankSector Rank
PE 33.96
Fwd PE 24.83
P/S 5.21
P/FCF 22.56
P/OCF 16.87
P/B 8.85
P/tB 9.17
EV/EBITDA 17.92
EPS(TTM)1.59
EY2.94%
EPS(NY)2.17
Fwd EY4.03%
FCF(TTM)2.39
FCFY4.43%
OCF(TTM)3.2
OCFY5.93%
SpS10.36
BVpS6.1
TBVpS5.89
PEG (NY)0.92
PEG (5Y)1.76
Graham Number14.7743 (-72.64%)
Profitability
Industry RankSector Rank
ROA 13.19%
ROE 30.46%
ROCE 23.93%
ROIC 18.92%
ROICexc 36.12%
ROICexgc 37.75%
OM 21.55%
PM (TTM) 17.94%
GM 62.09%
FCFM 23.11%
ROA(3y)10.24%
ROA(5y)8.29%
ROE(3y)28.01%
ROE(5y)22.13%
ROIC(3y)14.59%
ROIC(5y)11.66%
ROICexc(3y)37.89%
ROICexc(5y)31.72%
ROICexgc(3y)41.79%
ROICexgc(5y)35.48%
ROCE(3y)18.46%
ROCE(5y)14.75%
ROICexgc growth 3Y1.89%
ROICexgc growth 5Y6.96%
ROICexc growth 3Y7.33%
ROICexc growth 5Y6.44%
OM growth 3Y15.68%
OM growth 5Y5.09%
PM growth 3Y15.23%
PM growth 5Y-8.86%
GM growth 3Y-1.61%
GM growth 5Y-1.72%
F-Score8
Asset Turnover0.74
Health
Industry RankSector Rank
Debt/Equity 0.47
Debt/FCF 1.2
Debt/EBITDA 1.03
Cap/Depr 144.36%
Cap/Sales 7.8%
Interest Coverage 88.12
Cash Conversion 114.67%
Profit Quality 128.81%
Current Ratio 1.88
Quick Ratio 1.59
Altman-Z 6.21
F-Score8
WACC8.24%
ROIC/WACC2.3
Cap/Depr(3y)145.46%
Cap/Depr(5y)210.39%
Cap/Sales(3y)7.74%
Cap/Sales(5y)10.33%
Profit Quality(3y)110.93%
Profit Quality(5y)89.33%
High Growth Momentum
Growth
EPS 1Y (TTM)12.73%
EPS 3Y28.82%
EPS 5Y19.29%
EPS Q2Q%0%
EPS Next Y36.73%
EPS Next 2Y27.84%
EPS Next 3Y25.1%
EPS Next 5Y21.71%
Revenue 1Y (TTM)15.6%
Revenue growth 3Y17.01%
Revenue growth 5Y19.33%
Sales Q2Q%13.12%
Revenue Next Year12.62%
Revenue Next 2Y12.47%
Revenue Next 3Y12.38%
Revenue Next 5Y11.94%
EBIT growth 1Y53.73%
EBIT growth 3Y35.36%
EBIT growth 5Y25.41%
EBIT Next Year67.73%
EBIT Next 3Y32.66%
EBIT Next 5Y25.77%
FCF growth 1Y70.79%
FCF growth 3Y52.34%
FCF growth 5Y31.25%
OCF growth 1Y45.6%
OCF growth 3Y29.1%
OCF growth 5Y24.81%

DEXCOM INC / DC4.DE Fundamental Analysis FAQ

What is the ChartMill fundamental rating of DEXCOM INC (DC4.DE) stock?

ChartMill assigns a fundamental rating of 6 / 10 to DC4.DE.


What is the valuation status for DC4 stock?

ChartMill assigns a valuation rating of 4 / 10 to DEXCOM INC (DC4.DE). This can be considered as Fairly Valued.


What is the profitability of DC4 stock?

DEXCOM INC (DC4.DE) has a profitability rating of 8 / 10.


What are the PE and PB ratios of DEXCOM INC (DC4.DE) stock?

The Price/Earnings (PE) ratio for DEXCOM INC (DC4.DE) is 33.96 and the Price/Book (PB) ratio is 8.85.


What is the expected EPS growth for DEXCOM INC (DC4.DE) stock?

The Earnings per Share (EPS) of DEXCOM INC (DC4.DE) is expected to grow by 36.73% in the next year.